Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity
- PMID: 14695164
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity
Abstract
Whereas biallelic neurofibromatosis 1 (NF1) inactivation is observed in NF1-associated gliomas, astrocyte-restricted Nf1 conditional knockout mice do not develop gliomas. These observations suggest that NF1 glioma formation requires additional cellular or genetic conditions. To determine the effect of an Nf1 heterozygous brain environment on NF1 glioma formation, we generated Nf1+/- mice lacking Nf1 expression in astrocytes. In contrast to astrocyte-restricted Nf1 conditional knockout mice, Nf1+/- mice lacking Nf1 in astrocytes develop optic nerve gliomas. This mouse model demonstrates that Nf1+/- cells contribute to the pathogenesis of gliomas in NF1 and provides a tool for the preclinical evaluation of potential therapeutic interventions for these tumors.
Similar articles
-
Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.Hum Mol Genet. 2007 May 1;16(9):1098-112. doi: 10.1093/hmg/ddm059. Epub 2007 Mar 30. Hum Mol Genet. 2007. PMID: 17400655
-
Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.Cancer Res. 2005 Nov 1;65(21):9843-50. doi: 10.1158/0008-5472.CAN-05-1842. Cancer Res. 2005. PMID: 16267007
-
Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.Cancer Res. 2005 Jan 1;65(1):236-45. Cancer Res. 2005. PMID: 15665300
-
Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.J Neurosci Res. 2019 Jan;97(1):45-56. doi: 10.1002/jnr.24250. Epub 2018 Apr 28. J Neurosci Res. 2019. PMID: 29704429 Free PMC article. Review.
-
Nf1 gene targeting: toward models and mechanisms.Semin Cancer Biol. 1996 Oct;7(5):291-8. doi: 10.1006/scbi.1996.0037. Semin Cancer Biol. 1996. PMID: 9110406 Review.
Cited by
-
Modeling cognitive dysfunction in neurofibromatosis-1.Trends Neurosci. 2013 Apr;36(4):237-47. doi: 10.1016/j.tins.2012.12.002. Epub 2013 Jan 8. Trends Neurosci. 2013. PMID: 23312374 Free PMC article. Review.
-
Emerging insights into the molecular and cellular basis of glioblastoma.Genes Dev. 2012 Apr 15;26(8):756-84. doi: 10.1101/gad.187922.112. Genes Dev. 2012. PMID: 22508724 Free PMC article. Review.
-
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.Nat Rev Cancer. 2015 May;15(5):290-301. doi: 10.1038/nrc3911. Epub 2015 Apr 16. Nat Rev Cancer. 2015. PMID: 25877329 Free PMC article. Review.
-
Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiency.BMC Genomics. 2010 Mar 22;11:194. doi: 10.1186/1471-2164-11-194. BMC Genomics. 2010. PMID: 20307317 Free PMC article.
-
Using the neurofibromatosis tumor predisposition syndromes to understand normal nervous system development.Scientifica (Cairo). 2014;2014:915725. doi: 10.1155/2014/915725. Epub 2014 Aug 28. Scientifica (Cairo). 2014. PMID: 25243094 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous